Welcome to Medications.com

Hydrochlorothiazide-Lisinopril Information

What's inside Hydrochlorothiazide-Lisinopril

Hydrochlorothiazide-Lisinopril Active Ingredients: hydrochlorothiazide, lisinopril, details.
Hydrochlorothiazide-Lisinopril Dosages & Strengths
Strength Format Route Strength Class
Hydrochlorothiazide-Lisinopril 25 mg-20 mg tablet oral 1.0 each OTC
Hydrochlorothiazide-Lisinopril 12.5 mg-10 mg tablet oral 1.0 each OTC
Hydrochlorothiazide-Lisinopril 25 mg-20 mg tablet oral 1.0 each OTC
Hydrochlorothiazide-Lisinopril 12.5 mg-10 mg tablet oral 1.0 each OTC

Recent Hydrochlorothiazide-Lisinopril Side Effects

Posted by blessings09 about 14 hours ago
dry cough .heart pounding, /skipping beat ,. weepy ,.also tiredness when walking the same distance i usually wal, before taki...

Posted by tomneversfield 2 months ago
I just read many postings here regarding lisinopril/hctz and the sexual problems it had caused you. I'm a 26 year old male, j...

Posted by lindastout 3 months ago
nausea, stomach pain


Hydrochlorothiazide-Lisinopril Chemical Information

hydrochlorothiazide - The hydrogenated derivative of chlorothiazide, a thiazide diuretic with antihypertensive and anti-urolithic effects. This agent binds to the electroneutral Na-K-Cl cotransporter (NKCC) and thereby impairs Na+, K+ and Cl- reabsorption on the luminal membrane of the early segment in the distal convoluted tubule in the kidney. This leads to an increase in urinary excretion of sodium, chloride, potassium, bicarbonate and water subsequently reducing plasma and extracellular fluid volume leading to a reduction in blood pressure. Hydrochlorothiazide also decreases urinary calcium and uric acid excretion by direct action on the distal tubule.

lisinopril - A synthetic peptide derivate and long-acting angiotensin-converting enzyme (ACE) inhibitor with antihypertensive activity. Lisinopril specifically and competitively inhibits angiotensin-converting enzyme thereby decreasing the formation of the potent vasoconstrictor angiotensin II. This leads to a diminished vasopressor activity. In addition, angiotensin II-stimulated aldosterone secretion by adrenal cortex is decreased which results in a decrease of sodium and water retention and an increase of serum potassium.





© 2002-2007, Skylabs Inc.  |  About Us  |  Disclaimer/Terms of Use  |  Advertise  |  Contact Us  |  Site Map  |  Developed by: W3matter.com | Sleep Apnea